HelixoMetry, Inc. (Silicon Valley, USA) and BioChemiCon (Kent, UK) developed proprietary mathematical design tool (FractoGene, patent pending) and proprietary manufacturing equipment (respectively), in order to design and to manufacture “designer proteins”. Such proteins are used in BioTech (as potent drugs, like breast-cancer inhibitor Herceptin), in NanoTech (as nanofibers), and in InfoTech (where proteins in the millionth of millimeter range) will be used for “computers” of the future, e.g. attaining the densest possible data storage and processing. The USA and UK early stage companies jointly seek funding to secure and optimize for each other their proprietary patents (pending and in preparation).

CONTACT:
Andras J. Pellionisz
Founder & CEO of HelixoMetry, inc.
Sunnyvale, CA 94086
Phone: 408.891.7187
http://helixometry.com, http://fractogene.com
cob@helixometry.com

Walter Battistutti, Founder & CEO
BioChemiCon, the protein company
Kent TN1 1PA, United Kingdom
cell 43.664.543.2774
http://biochemicon.org
w.battistutti@biochemicon.org

Sunnyvale, CA – April 15, 2003 – HelixoMetry.com and Biochemicon.org announced today that they executed their Agreement towards Joint Venture in the field of “designer proteins”. Biochemicon (Kent, UK) already manufactures proteins with the use of proprietary technology (patent in preparation, existing initial markets are Pharma R&D). From their hard-earned experience Biochemicon leaders learnt that the “protein coding” (exon) sequences of the DNA are, alone, insufficient, and the already developed parts of proteins, together with the non-coding (“junk”) DNA (introns) regulate sophisticated growth. HelixoMetry (Silicon Valley, USA) submitted the FractoGene patent (pending) that is precisely such a (mathematical) design tool that interprets self-similar, repeated “non-coding DNA sequences” (introns) as fractal sets. The two early stage companies, therefore, joined forces in “Joint Venture” to optimize their funding, in order to secure proprietary technologies in the field of design and manufacturing of “designer proteins”, and to optimize their activities in global business development, market research, software specification, software development, protein design, protein manufacturing, marketing and sales.

HelixoMetry, Inc., a California Corporation was founded (early 2002) and privately financed by scientist-executive-entrepreneur Dr. Andras J. Pellionisz (see accomplishments at http://usa-siliconvalley.com/inst/pellionisz), to amass an intellectual portfolio for “the second 50 years of DNA”. Components are patents, award winning “know how” of advanced rule based, xml, natural language processing and neural net intelligence-architecture and software, as well as an algorithmic mathematical (fractal geometry) approach to interpret 98.7% of the human DNA (so-called “Junk DNA”). The Silicon Valley location is ideal for market research, business development, software specification and software design, as well as marketing and sales.

BioChemiCon, in Kent, (United Kingdom) was founded (late 2001) by Dr. Walter Battistutti to focus on “designer protein” manufacturing with proprietary equipment (patent in preparation). Beyond the cutting edge of the unique equipment, the early protein products (already on the market) convinced BioChemiCon that 2-dimensional process and one that uses exclusively “protein-coding” (exon) information are insufficient. Thus, the technology broke into the full 3 dimensions, and necessitates the utilization of information of “non-coding” (intron) DNA sequences, especially since it is now a consensus that “introns regulate gene expression”. Knowing the stripping the DNA of introns is lethal, and e.g. the Friedreich’ Spinocerebellar Ataxia (similar “aggregated protein” disease as Alzheimer’s, Huntington’s, Parkinson’s) is actually caused by an “run” in a well-specified intron.

HelixoMetry and BioChemiCon seek Joint Venture financing to secure and optimize for one-another their design- and manufacturing technologies, as well as build the full-spectrum (from market research to sales) of the fastest-growing and most potent industry, “designer proteins”.

For Additional Information, Please Contact: